(NASDAQ: AHCO) Adapthealth's forecast annual revenue growth rate of 1.92% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 18.89%.
Adapthealth's revenue in 2025 is $3,262,564,000.On average, 5 Wall Street analysts forecast AHCO's revenue for 2025 to be $447,443,176,575, with the lowest AHCO revenue forecast at $440,880,127,309, and the highest AHCO revenue forecast at $460,514,107,603.
In 2026, AHCO is forecast to generate $474,073,203,767 in revenue, with the lowest revenue forecast at $455,883,131,988 and the highest revenue forecast at $505,172,875,262.